Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world; multicenter observational study度鲁木单抗在泰国人群III期非小细胞肺癌患者中完成根治性放化疗后的应用:一项真实世界、多中心观察性研究Frontiers in OncologyIF3.32025-10-220OAAI
Exploring Prognostic Factors and Survival Outcomes in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy in Limited-Resource SettingsJOURNAL OF CLINICAL MEDICINEIF2.92025-01-080OAAI
Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational studyANNALS OF ONCOLOGYIF65.42023-10-010PRE
Efficacy of FOLFOX4 regimen with advanced hepatocellular carcinoma and prognostic factors for survivalANNALS OF ONCOLOGYIF65.42021-07-010OAAI
UTILITY OF PRE-TREATMENT SERUM AMPHIREGULIN IN COLORECTAL CARCINOMAEUROPEAN JOURNAL OF CANCERIF7.12014-05-011PREAI